CompletedNot Applicable

Trial of a Distal Targeting System for Cephalomedullary Nails as Part of Surgical Repair of Hip and Femoral Shaft Fractures

United States60 participantsStarted 2019-12-17

Plain-language summary

This study will be a prospective, case - control trial looking at the use of a previously FDA approved device made by Stryker, a distal targeting system that eases the distal targeting of screws in cephalomedullary nails in hip and femoral shaft fractures. Patients who consent to participate in the study will either be in the control or device arm of the study depending on their surgeon.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patient must be greater than or equal to 18 years of age. * The patient must have sustained a hip or femur fracture that is indicated for cephalomedullary nailing as the primary and definitive treatment measure. * The patient must be medically cleared for operative fixation of their fracture. Exclusion Criteria: * The patient does not meet all of the inclusion criteria.

What they're measuring

Change in mean intra-operative radiation exposure to patients during their cephalomedullary nailing procedure.

Timeframe: Baseline, 1 Day

Trial details

NCT IDNCT03943329

SponsorNYU Langone Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-07

View on ClinicalTrials.gov More Hip Fractures trials